13F 申報指南13F 觀念全攻略
什麼是 SEC Form 13F 申報？美股機構大戶持股全攻略
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制，學會如何追蹤頂級對沖基金與機構法人持倉動向。
AlphaSMO 權威研究指南閱讀專題
CIK: 0001858703
申報總市值
US$6.6億
US$6.6億
78 檔
31.4%
根據最新整理的 13F 季度數據集，Blue Owl Capital Holdings LP 於 Q4 2024 結束時的管理資產規模為 US$6.6億。該機構在本季度申報了 78 檔美股持倉，呈現出該時期的主要投資地圖。
在 Q4 2024，Blue Owl Capital Holdings LP 展現出較為審慎的避險與獲利了結姿態。本季共減碼 12 個部位並完全清倉 16 檔持股，調降曝險的部位數量高於加碼動作。
檢視投資組合結構，前 5 大主力部位（包含 NCDL, KVYO, PLRX）占據了總市值的 31.4%，展現出該機構在 Q4 2024 的重點資金聚焦與風險分佈特徵。
| # | 代號 | 標的名稱 | 資產子類別 | 佔比 | 佔比變動 | 持倉量變化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NCDL | Nuveen Churchill Direct Lend | 股票-其他 | 15.99% | -3.32% | — | |
| 2 | KVYO | Klaviyo Inc-a | 股票-其他 | 10.49% | — | -9.97% | |
| 3 | PLRX | Pliant Therapeutics Inc | 股票-其他 | 8.60% | -1.01% | EXIT | |
| 4 | OBDC | Blue Owl Capital CORP | 股票-金融 | 7.29% | -2.73% | — | |
| 5 | CGEM | Cullinan Therapeutics Inc | 股票-其他 | 6.81% | -3.07% | +17.90% | |
| 6 | CNDT | Conduent Inc | 股票-其他 | 5.36% | -0.62% | +67.27% | |
| 7 | TRML | Tourmaline Bio Inc | 股票-其他 | 5.16% | — | -29.47% | |
| 8 | ✓ | Engene Holdings Inc | 股票-其他 | 4.96% | -8.08% | EXIT | |
| 9 | EVCM | Evercommerce Inc | 股票-其他 | 4.26% | — | — | |
| 10 | LRMR | Larimar Therapeutics Inc | 股票-其他 | 4.25% | -4.40% | +11.67% | |
| 11 | HLLY | Holley Inc | 股票-其他 | 2.13% | -1.81% | +17.56% | |
| 12 | ✓ | Acelyrin Inc | 股票-其他 | 2.06% | — | -0.36% | |
| 13 | ELDN | Eledon Pharmaceuticals Inc | 股票-其他 | 1.90% | -0.84% | — | |
| 14 | IRON | Disc Medicine Inc | 股票-其他 | 1.80% | — | -31.38% | |
| 15 | ✓ | Ikena Oncology Inc | 股票-其他 | 1.58% | — | — | |
| 16 | CNTX | Context Therapeutics Inc | 股票-其他 | 1.57% | -3.34% | +17.49% | |
| 17 | SGMT | Sagimet Biosciences Inc-a | 股票-其他 | 1.41% | +1.00% | -20.91% | |
| 18 | TNGX | Tango Therapeutics Inc | 股票-其他 | 1.26% | — | — | |
| 19 | RARE | Ultragenyx Pharmaceutical In | 股票-其他 | 1.17% | -0.78% | -27.57% | |
| 20 | EYPT | Eyepoint Inc | 股票-其他 | 1.17% | -1.52% | — | |
| 21 | RPTX | Repare Therapeutics Inc | 股票-其他 | 1.06% | — | +2.11% | |
| 22 | ETWOGBP | E2open Parent Holdings Inc | 股票-其他 | 1.04% | — | — | |
| 23 | CMPX | Compass Therapeutics Inc | 股票-其他 | 1.01% | -2.99% | +2.60% | |
| 24 | KROS | Keros Therapeutics Inc | 股票-其他 | 0.91% | — | +97.85% | |
| 25 | 260 | Centessa Pharmaceuticals-adr | 股票-其他 | 0.87% | — | -13.73% | |
| 26 | AQST | Aquestive Therapeutics Inc | 股票-其他 | 0.76% | -0.91% | -26.53% | |
| 27 | PVLA | Palvella Therapeutics Inc | 股票-其他 | 0.71% | -0.22% | — | |
| 28 | ✓ | Inozyme Pharma Inc | 股票-其他 | 0.71% | — | -3.57% | |
| 29 | MREO | Mereo Biopharma Group Pl-adr | 股票-其他 | 0.56% | — | -20.64% | |
| 30 | MRKR | Marker Therapeutics Inc | 股票-其他 | 0.41% | -0.07% | — | |
| 31 | ✓ | 股票-其他 | 0.39% | — | -8.73% | ||
| 32 | ✓ | Adc Therapeutics SA | 股票-其他 | 0.34% | -0.58% | — | |
| 33 | GOCOQ | Gohealth Inc-class A | 股票-其他 | 0.26% | -0.02% | EXIT | |
| 34 | EPD | Enterprise Products Partners | 股票-能源 | 0.23% | -0.32% | EXIT | |
| 35 | OHI | Omega Healthcare Investors, Inc. | 股票-房地產 | 0.19% | — | — | |
| 36 | ✓ | 股票-其他 | 0.16% | — | — | ||
| 37 | ✓ | 股票-其他 | 0.16% | — | — | ||
| 38 | ✓ | Marblegate Acquisition Corp | 股票-其他 | 0.15% | — | — | |
| 39 | CMPS | Compass Pathways PLC | 股票-其他 | 0.14% | +0.96% | NEW | |
| 40 | GTLB | Gitlab Inc-cl A | 股票-科技 | 0.13% | — | — | |
| 41 | ROIV | Roivant Sciences Ltd. | 股票-醫療保健 | 0.11% | — | — | |
| 42 | ✓ | Rezolve Ai LTD | 股票-其他 | 0.11% | -0.02% | — | |
| 43 | ✓ | Alpha Partners Technology Merg | 股票-其他 | 0.05% | — | — | |
| 44 | SLND-WS | Legato Merger CORP Ii -cw23 | 股票-其他 | 0.05% | -0.01% | — | |
| 45 | CAH | Cardinal Health Inc | 股票-醫療保健 | 0.05% | -0.10% | EXIT | |
| 46 | OPTX | Syntec Optics Holdings Inc | 股票-其他 | 0.03% | — | — | |
| 47 | AMODW | Insight Acquisition Co -cw23 | 股票-其他 | 0.02% | -0.01% | — | |
| 48 | PLMKW | Plum Acquisition Corp. IV | 股票-其他 | 0.02% | — | — | |
| 49 | OPTXW | Omnilit Acquisition Cl A -23 | 股票-其他 | 0.02% | -0.23% | EXIT | |
| 50 | ✓ | Satixfy Communications LTD | 股票-其他 | 0.02% | — | — |
| # | 代號 | 標的名稱 | 佔比變動 | 持倉量變化 | 異動類型 |
|---|---|---|---|---|---|
| 1 | CNDT | Conduent Inc | +2.6% | +67.27% | 加碼 |
| 2 | GOCOQ | Gohealth Inc-class A | +2.4% | — | 不變 |
| 3 | KVYO | Klaviyo Inc-a | +2.1% | -9.97% | 減碼 |
| 4 | NCDL | Nuveen Churchill Direct Lend | +2.1% | — | 不變 |
| 5 | PLRX | Pliant Therapeutics Inc | +1.9% | -7.82% | 減碼 |
| 6 | ELDN | Eledon Pharmaceuticals Inc | +1.9% | NEW | 新建倉 |
| 7 | OBDC | Blue Owl Capital CORP | +1.4% | — | 不變 |
| 8 | TNGX | Tango Therapeutics Inc | +1.2% | NEW | 新建倉 |
| 9 | EYPT | Eyepoint Inc | +1.2% | NEW | 新建倉 |
| 10 | ✓ | Engene Holdings Inc | +1% | +3.30% | 加碼 |
| 11 | EVCM | Evercommerce Inc | +0.9% | — | 不變 |
| 12 | PVLA | Palvella Therapeutics Inc | +0.7% | NEW | 新建倉 |
| 13 | HLLY | Holley Inc | +0.6% | +17.56% | 加碼 |
| 14 | SGMT | Sagimet Biosciences Inc-a | +0.5% | -20.91% | 減碼 |
| 15 | MRKR | Marker Therapeutics Inc | +0.4% | NEW | 新建倉 |
| 16 | CGEM | Cullinan Therapeutics Inc | +0.2% | +17.90% | 加碼 |
| 17 | ✓ | +0.2% | NEW | 新建倉 | |
| 18 | CMPS | Compass Pathways PLC | +0.1% | NEW | 新建倉 |
| 19 | IRON | Disc Medicine Inc | +0.1% | -31.38% | 減碼 |
| 20 | CMPX | Compass Therapeutics Inc | 0% | +2.60% | 加碼 |
| 21 | ✓ | Adc Therapeutics SA | -0.1% | — | 不變 |
| 22 | MREO | Mereo Biopharma Group Pl-adr | -0.1% | -20.64% | 減碼 |
| 23 | ✓ | Engene Holdings Inc | -0.1% | -92.94% | 減碼 |
| 24 | TQQQ | ProShares UltraPro QQQ | -0.1% | EXIT | 清倉 |
| 25 | SYRS | Syros Pharmaceuticals Inc | -0.2% | EXIT | 清倉 |
| 26 | NU | Nu Holdings Ltd. | -0.2% | EXIT | 清倉 |
| 27 | BLND | Blend Labs Inc-a | -0.3% | EXIT | 清倉 |
| 28 | PAYO | Payoneer Global Inc | -0.3% | EXIT | 清倉 |
| 29 | ✓ | -0.3% | -8.73% | 減碼 | |
| 30 | ETWOGBP | E2open Parent Holdings Inc | -0.4% | — | 不變 |
| 31 | AQST | Aquestive Therapeutics Inc | -0.4% | -26.53% | 減碼 |
| 32 | ✓ | Inozyme Pharma Inc | -0.4% | -3.57% | 減碼 |
| 33 | IMVT | Immunovant Inc | -0.4% | EXIT | 清倉 |
| 34 | MLYS | Mineralys Therapeutics Inc | -0.5% | EXIT | 清倉 |
| 35 | KROS | Keros Therapeutics Inc | -0.5% | +97.85% | 加碼 |
| 36 | BRZE | Braze Inc-a | -0.5% | EXIT | 清倉 |
| 37 | VKTX | Viking Therapeutics Inc | -0.5% | EXIT | 清倉 |
| 38 | CNTX | Context Therapeutics Inc | -0.5% | +17.49% | 加碼 |
| 39 | GPCR | Structure Therapeutics Inc | -0.6% | EXIT | 清倉 |
| 40 | RARE | Ultragenyx Pharmaceutical In | -0.6% | -27.57% | 減碼 |
| 41 | ✓ | Acelyrin Inc | -0.7% | -0.36% | 減碼 |
| 42 | JANX | Janux Therapeutics Inc | -0.7% | EXIT | 清倉 |
| 43 | PYXS | Pyxis Oncology Inc | -0.8% | EXIT | 清倉 |
| 44 | STWD | Starwood Property Trust Inc | -0.9% | EXIT | 清倉 |
| 45 | CCC | Ccc Intelligent Solutions Ho | -1% | EXIT | 清倉 |
| 46 | ✓ | Lanzatech Global Inc | -1.1% | EXIT | 清倉 |
| 47 | LRMR | Larimar Therapeutics Inc | -1.1% | +11.67% | 加碼 |
| 48 | RPTX | Repare Therapeutics Inc | -1.2% | +2.11% | 加碼 |
| 49 | TRML | Tourmaline Bio Inc | -2.6% | -29.47% | 減碼 |
| 50 | TQQQ | Proshares Ultrapro Qqq | -4.5% | EXIT | 清倉 |
根據 SEC 官方 Form 13F 申報備案，Blue Owl Capital Holdings LP 在 Q4 2024 季度的美股持倉總市值約為 US$6.6億，共申報了 78 個公開持股部位。
在 Q4 2024 季度，Blue Owl Capital Holdings LP 按市值排列的前三大核心持股分別為：NCDL (16.0%)、KVYO (10.5%)、PLRX (8.6%)。其中最大持股部位 NCDL 佔據整體投資組合約 16.0% 的權重。
精選 AlphaSMO 大戶持股與內部人交易深度分析，提升投資決策勝率
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制，學會如何追蹤頂級對沖基金與機構法人持倉動向。
本季最大新建倉標的
ELDN
市值: US$807.5萬
本季最大獲利了結 / 清倉標的
TQQQ
前期市值: US$2355.9萬
在 Q4 2024 季度中，Blue Owl Capital Holdings LP 共進行了 44 項持倉異動，包含新建倉 7 個部位、加碼 9 個部位、減碼 12 個部位以及清倉 16 個部位。 其中最大新建倉標的為 ELDN。 本季清倉部位包含 TQQQ。
本頁面所有持股數據均直接同步自美國證券交易委員會（SEC）EDGAR 官方系統之 13F-HR / 13F-HR/A 季度申報文件。AlphaSMO 透過機器解析 CUSIP 與個股對照，提供 100% 精準對齊的歷史時序數據集，並支援 Schema.org 結構化資料格式。
解析公司高管、董事與 10% 大股東之 Form 4 內部人交易申報，掌握高管自家股票買賣第一手訊號。
深入剖析 5% 股益申報門檻、13D 與 13G 之差異，以及最新 SEC 申報時程規範，洞察機構法人的激進投資動向。